Welltech Ventures

The firm focuses on early-stage investments, primarily seed and Series A rounds. This stage preference allows it to partner with founders early in a company's lifecycle, when product-market fit is still being refined and strategic support from a specialist investor is most impactful.

The firm invests across fitness technology, mental health platforms, personalized nutrition, digital therapeutics, and longevity science. It targets businesses where software, data science, and behavioral science intersect with health outcomes, distinguishing it from generalist health-tech funds.

No. While the firm is headquartered in Tel Aviv and benefits from Israel's deep health-tech talent pool, its investment scope is global. It has backed companies in North America and Europe, targeting the most promising wellness startups regardless of geography.

Deal flow is driven by the firm's dedicated focus on the wellness vertical, its presence in Israel's health-tech ecosystem, and relationships with accelerators, academic research institutions, and co-investors active in digital health. Its specialization creates a referral network of founders and GPs who route relevant opportunities to the firm.

The firm participates in both lead and co-investment capacities, often syndicating alongside other specialist health-tech venture funds. This flexible approach allows it to back companies at various check sizes and to support rounds where sector expertise is more critical than capital alone.